Rosuvastatin Completed Phase 3 Trials for Dyslipidemias / High Blood Pressure (Hypertension) Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT0065460248-wk Open Label Phase IIIb to Evaluate Efficacy and Safety
NCT03026933Evaluate the Efficacy and Safety of KI1107 in Patients Whose TG Level is Not Adequately Controlled With Rosuvastatin Calcium Monotherapy While LDL-C is Properly Controlled
NCT03210532Evaluate the Efficacy and Safety of Combination Treatment With DW1501-R1+DW1501-R2 Versus DW1501-R1 or DW1501-R2+DW1501-R3 in Patients With Hypertension and Dyslipidemia
NCT01764295Clinical Study for Patients With Hypertension Associated With Dyslipidemia